Reach Us +44-1647-403003
Editor - Gal Bitan | University of California | 5585
ISSN: 2167-7182

Journal of Gerontology & Geriatric Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Relevant Topics

Gal Bitan

Gal Bitan
Executive Editor
Gal Bitan, PhD
Associate Professor
University of California

University of California


Gal Bitan completed his graduate studies in organic chemistry at the Hebrew University of Jerusalem, Israel. He is a co-inventor of patented methodologies for peptide cyclization, which formed the basis for creation of the biotechnology company Peptor, Inc. In his postdoctoral studies on protein misfolding and aggregation at Brigham and Women’s Hospital and Harvard Medical School, Dr. Bitan has made fundamental contributions to the study of early events in the pathologic cascades that cause Alzheimer′s disease. He introduced the use of novel photochemical protein cross-linking techniques for investigation of amyloid β-protein assembly and discovered one of the earliest oligomers in the assembly cascade, the paranucleus. In 2004, Dr. Bitan joined UCLA where he is currently an Associate Professor. His research focuses on novel therapeutic strategies for protein misfolding diseases, such as Alzheimer’s, Parkinson’s, and type-2 diabetes. In recognition of his achievements, in 2005, Dr. Bitan received the Turken research award.

Research Interest

Mechanisms of aberrant protein aggregation
Amyloid-related diseases
Mechanisms of amyloid formation
Non-fibrillar assemblies of amyloid forming proteins
Oxidative stress in neurodegenerative diseases and aging
Structure-activity relationships of amyloid forming proteins
Structure-based drug design for amyloid-related diseases
Peptide-based modulators of amyloid protein self-assembly
Small-molecule modulators of amyloid protein self-assembly



Global Speakers in the subject

Global Experts in the subject


Can We Accelerate the Path towards Therapy for Amyloid-Related Diseases?

Gal Bitan
Editorial: J Gerontol Geriatric Res 2012, 1: e106
DOI: 10.4172/2167-7182.1000e106